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Background
Recently HIV infected individuals are followed up at
Rwanda-Zambia HIV Research Group (RZHRG) sites to
establish markers of disease progression. Here we compare
disease progression between seroconverters infected by
their spouses (linked transmission) to those infected by
non-spousal partners (unlinked transmission) where a
greater fraction of individuals are infected by multiple
virus variants.
Methods
Seroconverters (SC) were identified from HIV discordant
couples enrolled from the Couples’ VCT program into a
prospective cohort study. Linkage of transmission was
established by comparing viral DNA sequences in the SC
to that of the suspected index partner. SCs were followed
up to six years to collect clinical and laboratory data. Data
analysis using STATA was done on CD4 and viral load
trajectories and a comparison of disease progression with
respect to time to endpoints of CD4 <350 cells/uL and
initiation of ARVs. Log rank test of equality for survival
function was performed for each endpoint and p-values
calculated.
Results
From February 2006 to December 2011, 88 unlinked and
225 linked transmissions were identified. Across all
RZHRG sites, SC males represented 56% of the unlinked
and 55% of the linked group. Overall mean age at serocon-
version was 33 years and 69% of HIV transmissions were
acute infections (identified within 90 days of infections).
Mean CD4 count and viral load at specified time points
during a six year follow up period of the two groups were
similar. Disease progression in the two groups (CD4
<350cell/uL or initiation of ARVs) showed no significant
difference (p=0.21 and p=0.26) respectively.
Conclusion
Despite the fact that previous studies have shown that
there is faster disease progression in individuals who
were infected by multiple genetic variants from their
partner, we show here that linkage status does not pre-
dict HIV disease progression in HIV seroconverting
couples.
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